Special Issue "Management of COVID-19 through Vaccination: Past, Current and Future Strategies"
Deadline for manuscript submissions: 28 February 2024 | Viewed by 106
The last three years of the COVID-19 pandemic have recorded some of the best public health interventions, including the development of surveillance systems and tools, and widespread non-pharmaceutical interventions such as lock-downs and stay-at-home restrictions. Furthermore, pharmaceutical control, including vaccination, testing and antiviral treatment, has highly contributed to the reduction in the severity of the disease, and in turn reduced the burden on healthcare systems, globally. In many places, these control strategies were used alongside public involvement, sound policy and active communication, as described by Stenseth and colleagues. Nevertheless, unfavorable health impacts, including hospitalization and deaths, were reported. In Australia, an estimated 3.5% excess deaths were recorded in 2021 compared to −1.2% in 2020 and 0.9% in 2019. Additionally, the pandemic also highlighted key social determinants of health affecting the rollout of vaccination and other control strategies in certain populations and regions.
This Special Issue will aim to disseminate empirical evidence of the success and challenges faced in the implementation of vaccination and other control strategies used to manage COVID-19 cases and outbreaks within various populations. Articles reflecting on the contribution, utilization, regulation, epidemiology and the safety of COVID-19 vaccination and other public health control strategies will be given a higher priority. Articles providing insights into the future of COVID-19 vaccination, as well as those describing the lessons learned to control future epidemics, will be highly considered.
I am pleased to invite you and any members of your research team to submit manuscripts for this Special Issue of the Vaccines journal. The Vaccines journal is an international, peer-reviewed open access journal focused on laboratory and clinical vaccine research, utilization and immunization. Original research articles, reviews and opinion pieces are welcome.
I look forward to receiving your contributions.
Dr. Michael Muleme
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- COVID-19 transmission
- vaccine safety
- vaccine utilisation
- control strategies